Saturday, November 04, 2006

Another medico legal issue rocks America.

It seems there is no end to the miseries of U.S. citizens who are ever vulnerable to defective medications and medical devices. It is such a pity that they are affected by medicines that are initially approved by US Food and Drug Administration but are later found to produce harmful side effects.

The drug in dispute is fosamax, manufactured by Merck and used for treating Osteoporosis.

It is believed that Fosamax and other similar bisphosphonate drugs may cause osteonecrosis of the jaw by blocking the normal reproduction of bone cells.

Ok, I will clear your confusion.

Osteoporosis, a disease of bone in which the bone mineral density (BMD) is reduced. Mostly women who have passed menopause are affected by this disease. Smoking is also considered as one of the causes apart from calcium and vitamin D deficiencies.

Osteonecrosis of the jaw (ONJ) is also commonly referred to as "dead jaw" and “fossy jaw”.

Hundreds of patients who are diagnosed with osteonecrosis of the jaw, have sought expert legal help from Parker & Waichman, LLP, the leader in defective pharmaceutical litigation.

The American Dental Association also took action by asking patients of Osteoporosis to notify their physician or dentist immediately if they have taken a bisphosphonate medication.

The ADA also recommends that patients tell their physicians and dentists that they are taking bisphosphonate medications before any dental work is performed.

It seems that in matters of such crisis, Parker & Waichman, LLP is the automatic choice being a leading products liability and personal injury law firm.

The firm is currently representing individuals injured by Vioxx, Bextra, Zyprexa, Ketek, and ReNu with MoistureLoc, Guidant Defibrillators and many other defective drugs and medical products.

For more information on Parker & Waichman, LLP, please visit:

Kindly Bookmark and Share it: